Type and hit ENTER

persistent-retina

Share

persistent-retina

July 3, 2017

-

Posted by Webmaster

July 3, 2017

No comments yet

Related News

Other posts that you should not miss.

News

ProAxsis makes significant progress towards measuring bone health with a new innovation for patients at high risk of osteoporotic fractures

October 20, 2021

-

Posted by Jessica Robinson

ProAxsis is delighted to announce the approval of a key US patent for the underlying technology associated …

October 20, 2021

Posted by Jessica Robinson

News

ProAxsis Ltd CEO Update Report – End Q4 2021

January 7, 2022

-

Posted by Jessica Robinson

Introduction As 2022 commences, I am pleased to provide an update on the progress made with regard …

January 7, 2022

Posted by Jessica Robinson

News

ProAxsis announces commercial team expansion

June 21, 2021

-

Posted by David Ribeiro

As part of its ongoing expansion plans, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce …

June 21, 2021

Posted by David Ribeiro

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Your comment

Name (required)

Email (required)

Website

Notify me of new posts by email.

Please wait...

ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test

June 7, 2021
ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it …
ProAxsis Ltd CEO Update Report – May 2021

May 21, 2021
Introduction In parallel with the release of the company’s 2020 financial statements, I …
ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases

February 21, 2021
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of …

Copyright © 2016-2021 - ProAxsis - All rights reserved.

persistent-retina - ProAxsis